Donatella Del Bufalo
- Cancer Research top 2%
- Cancer, Hypoxia, and Metabolism 13
- Oncology top 2%
- Molecular Biology top 2%
- Cell death mechanisms and regulation 21
- RNA Interference and Gene Delivery 14
- Histone Deacetylase Inhibitors Research 14
- Angiogenesis and VEGF in Cancer 13
- Ubiquitin and proteasome pathways 9
- PI3K/AKT/mTOR signaling in cancer 8
- Physiology top 1%
- Immunology top 5%
-
- Cell Adhesion Molecules Research 9
- Co-authors
- Daniela TrisciuoglioGabriella ZupiAnnamaria BiroccioMarianna DesideriChiara GabelliniSimona D’AguannoMarta Di MartileAntonio Candiloro
- Journals
- Proceedings of the National Academy of Sciences (1 paper)Journal of Biological Chemistry (1 paper)Journal of Clinical Investigation (1 paper)
- Partner nations
- ItalyMalaysiaUnited States
In The Last Decade
Donatella Del Bufalo
128 papers receiving 4.6k citations
Peers
Comparison fields: 5 of 122
- Cancer Research 1.0k
- Oncology 1.4k
- Molecular Biology 3.0k
- Physiology 192
- Immunology 650
Countries citing papers authored by Donatella Del Bufalo
This map shows the geographic impact of Donatella Del Bufalo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Donatella Del Bufalo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Donatella Del Bufalo more than expected).
Fields of papers citing papers by Donatella Del Bufalo
This network shows the impact of papers produced by Donatella Del Bufalo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Donatella Del Bufalo. The network helps show where Donatella Del Bufalo may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Donatella Del Bufalo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2023 | 1 | |
| 4 | 2023 | 4 | |
| 5 | 2023 | 8 | |
| 6 | 2023 | 12 | |
| 7 | 2022 | 19 | |
| 8 | 2022 | 4 | |
| 9 | 2021 | 7 | |
| 10 | 2020 | 27 | |
| 11 | 2020 | 59 | |
| 12 | 2020 | 6 | |
| 13 | 2020 | 52 | |
| 14 | 2017 | 18 | |
| 15 | 2014 | 13 | |
| 16 | 2013 | 17 | |
| 17 | 2013 | 29 | |
| 18 | 2011 | 50 | |
| 19 | 2004 | 27 | |
| 20 | The oral selective EGFR tyrosine kinase inhibitor (EGFR-TKI) ZD1839 (Iressa) potentiates taxane activity in multidrug-resistant MCF-7 ADR human breast cancer cells that overexpress the bcl-2 gene | 2001 | 0 |
About Donatella Del Bufalo
Donatella Del Bufalo is a scholar working on Cancer Research, Immunology and Allergy and Oncology, having authored 133 papers that have together received 4.7k indexed citations. Recurring topics across this work include Cell death mechanisms and regulation (21 papers), RNA Interference and Gene Delivery (14 papers), Histone Deacetylase Inhibitors Research (14 papers), Angiogenesis and VEGF in Cancer (13 papers), Cancer, Hypoxia, and Metabolism (13 papers), Ubiquitin and proteasome pathways (9 papers), Cell Adhesion Molecules Research (9 papers) and PI3K/AKT/mTOR signaling in cancer (8 papers). The work is most often cited by research in Cancer Research (1.0k citations), Oncology (1.4k citations) and Molecular Biology (3.0k citations). Donatella Del Bufalo has collaborated with scholars based in Italy, Malaysia and United States. Frequent co-authors include Daniela Trisciuoglio, Gabriella Zupi, Annamaria Biroccio, Marianna Desideri, Chiara Gabellini, Simona D’Aguanno, Marta Di Martile, Antonio Candiloro, Michèle Milella and Carlo Leonetti. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.